May 21, 2012

Drugmakers Pledge Transparency to Tackle Credibility Problem in Journal


Eight leading pharmaceutical companies have approved 10 recommendations aimed at improving transparency to address what they call a “credibility gap” that faces industry-funded clinical research. “Some observers, including some journal editors and academic reviewers, maintain a persistent negative view of industry-sponsored studies,” said an article in May’s Mayo Clinic Proceedings, co-written by 11 drug industry representatives and medical journal editors.


American Medical News by Kevin O’Reilly

Tags: American Medical News, credibility gap, Mayo Clinic Proceedings, Pharmacology, Research

Please sign in or register to post a reply.
Contact Us · Privacy Policy